Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Restricted countries Most countries in North America, Europe, and Asia permit personal-use quantities of prescription injectable medications without special permits
More lawsuits are expected to be filed as this litigation continues to grow
Frequent and prolonged vomiting (more than two weeks) Stomach paralysis (gastroparesis) the most common injury in the federal litigation Intestinal blockage (paralytic ileus) Bowel obstruction Gallbladder disease gallstones and gallbladder inflammation Pancreatitis Kidney damage, including acute kidney injury (AKI) Thyroid cancer and thyroid tumors Sudden vision loss (NAION) now its own federal MDL Injuries from compounded or counterfeit semaglutide and tirzepatide The GLP-1 litigation landscape changes regularly new MDLs open, label warnings are added, and filing deadlines shift
Most cases require a more specific E11.x diagnosis code to reflect complications such as neuropathy, chronic kidney disease (CKD), retinopathy, or hyperglycemia
US$ 24.17
US$ 20.65
US$ 23.06
US$ 27.31
US$ 22.46
US$ 22.50
US$ 28.49
